CompletedNot Applicable

PENG Block for Traumatic Hip Fracture in the Emergency Department

Taiwan65 participantsStarted 2021-08-30

Plain-language summary

The study is a multicenter single-blinded randomized comparative trial. Adult patients older than 20 years of age presenting with acute hip fracture in emergency department between January 1st, 2021 and December 31st, 2021 will be enrolled. (NOTE: The study was paused temporarily due to local SARS-2 COVID-19 virus pandemic restrictions. Finally, we conducted the study from August 30th, 2021 to May 08th, 2022.) Included patients will receive analgesia with either pericapsular nerve group (PENG) block or intravenous morphine. The primary outcome measure was pain scores (Numeric Rating Scale (NRS) 0 to 10) at rest and with movement. Secondary outcomes were rescue opioids use, complications, length of hospital stay, and patient-reported outcomes.

Who can participate

Age range20 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients aged \>20 years presenting to the ED with a diagnosis of traumatic hip fracture during the study timeframe. Exclusion Criteria: * are aged \<20 years * coagulopathy * injection site infection * allergy to opioids or local anesthetics * initial pulse oximetry measures of oxygen saturation \<92% * initial systolic blood pressure \< 90 mmHg * chronic opioid use * non-communicative * major trauma * fractures happened \> 24 hours * request conservative(non-operative) treatments. * The investigators also exclude patients if the NB providers are unavailable.

What they're measuring

Pain intensity difference (PID)

Timeframe: 24 hours

Trial details

NCT IDNCT04997785

SponsorDalin Tzu Chi General Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-05-08

View on ClinicalTrials.gov More Hip Fractures trials